Literature DB >> 7074401

The in-vitro caffeine contracture test: influence of the muscle histochemical profile on test results.

A K Brownell, M Szabo.   

Abstract

In vitro caffeine contracture tests were carried out on whole rat muscle composed primarily of either histochemical type I or type II fibers. Muscles composed primarily of type I fibers developed contractures at lower concentrations of caffeine and had lower caffeine specific concentrations than muscles composed primarily of type II fibers. These findings indicate that the histochemical profile of a muscle can influence the results of the in-vitro caffeine contracture test.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7074401     DOI： 10.1007/bf03007119

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN： 0008-2856


  11 in total

1.  Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations.

Authors:  B A Britt; L Endrenyi; P L Peters; F H Kwong; L Kadijevic
Journal:  Can Anaesth Soc J       Date:  1976-05

2.  Hindlimb muscle fiber populations of five mammals.

Authors:  M A Ariano; R B Armstrong; V R Edgerton
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

3.  Possible predictive tests for malignant hyperthermia during anesthesia.

Authors:  J A Aldrete; A Padfield; C C Solomon; M W Rubright
Journal:  JAMA       Date:  1971-03-01       Impact factor: 56.272

4.  The caffeine test of isolated human muscle in relation to malignant hyperthermia.

Authors:  W Kalow; B A Britt; A Richter
Journal:  Can Anaesth Soc J       Date:  1977-11

5.  Metabolic error of muscle metabolism after recovery from malignant hyperthermia.

Authors:  W Kalow; B A Britt; M E Terreau; C Haist
Journal:  Lancet       Date:  1970-10-31       Impact factor: 79.321

6.  Effect of temperature, time and fascicle size on the caffeine contracture test.

Authors:  B A Britt; L Endrenyi; E Scott; W Frodis
Journal:  Can Anaesth Soc J       Date:  1980-01

7.  Screening for malignant hyperthermia with a platelet bioassay.

Authors:  C C Solomons; N McDermott; M Mahowald
Journal:  N Engl J Med       Date:  1980-09-11       Impact factor: 91.245

8.  Malignant hyperpyrexia with anesthesia.

Authors:  R D Wilson; T E Dent; D L Traber; N R McCoy; C R Allen
Journal:  JAMA       Date:  1967-10-16       Impact factor: 56.272

9.  The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility.

Authors:  B A Britt; L Endrenyi; W Kalow; P L Peters
Journal:  Can Anaesth Soc J       Date:  1976-11

Review 10.  Malignant hyperthermia.

Authors:  G A Gronert
Journal:  Anesthesiology       Date:  1980-11       Impact factor: 7.892
View more
  3 in total

Review 1.  Malignant hyperthermia susceptibility: biochemical basis for pathogenesis and diagnosis.

Authors:  P J O'Brien; A Klip; B A Britt; B I Kalow
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

2.  Canine malignant hyperthermia: diagnosis of susceptibility in a breeding colony.

Authors:  P J O'brien; P H Cribb; R J White; E D Olfert; J E Steiss
Journal:  Can Vet J       Date:  1983-06       Impact factor: 1.008

3.  Microdialysis and ultrasound elastography for monitoring of localized muscular reaction after pharmacological stimulation in rats.

Authors:  Stephan Johannsen; Martin Schick; Norbert Roewer; Frank Schuster
Journal:  BMC Res Notes       Date:  2018-09-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.